Venus Remedies registers with DSIR to avail custom duty exemption

14 Sep 2023 Evaluate

Venus Remedies has made registration with Department of Scientific and Industrial Research (DSIR), Ministry of Science & Technology, Government of India. This significant milestone allows the company to avail custom duty exemption, reinforcing its commitment to innovation, excellence in research, and its substantial contributions to the healthcare sector.

This registration with DSIR exemplifies Venus Remedies' dedication to fostering innovation and making healthcare solutions more accessible. With a strong track record of brining 15 patented products to market and a robust pipeline of innovative pharmaceuticals, the company has consistently demonstrated a forward-thinking approach to drug development.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.

Venus Remedies Share Price

760.00 -25.35 (-3.23%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×